Evidence map›Paper›PMID 18483179›Full record

ArticleMolecular endocrinology (Baltimore, Md.)2008

Glucocorticoid receptor phosphorylation differentially affects target gene expression.

Weiwei Chen, Thoa Dang, Raymond D Blind, Zhen Wang, Claudio N Cavasotto, Adam B Hittelman, Inez Rogatsky, Susan K Logan, Michael J Garabedian

Open access · greenAbstract read
In one paragraph

Article in Molecular endocrinology (Baltimore, Md.), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 150 papers.

0numbers the graph read from it
0cells of the map it votes in
150citing papers in PubMed
11.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

150 citing papers in PubMed, 274 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

90 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Weiwei ChenDepartment of Pharmacology, and the NYU Cancer Institute, NYU School of Medicine, 550 First Avenue, New York, New York 10016, USA.
Thoa Dang
Raymond D Blind
Zhen Wang
Claudio N Cavasotto
Adam B Hittelman
Inez Rogatsky
Susan K Logan
Michael J Garabedian
New York University · USCornell University · US

Funding

REGULATION OF GLUCOCORTICOID RECEPTOR BY PHOSPHORYLATIONR01DK054836 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI GARABEDIAN, MICHAEL J · 1999 to 2002
$952k
NIDDK NIH HHS DK54836NIDDK NIH HHS R01 DK054836
6 · The paper itself

Abstract

The glucocorticoid receptor (GR) is phosphorylated at multiple sites within its N terminus (S203, S211, S226), yet the role of phosphorylation in receptor function is not understood. Using a range of agonists and GR phosphorylation site-specific antibodies, we demonstrated that GR transcriptional activation is greatest when the relative phosphorylation of S211 exceeds that of S226. Consistent with this finding, a replacement of S226 with an alanine enhances GR transcriptional response. Using a battery of compounds that perturb different signaling pathways, we found that BAPTA-AM, a chelator of intracellular divalent cations, and curcumin, a natural product with antiinflammatory properties, reduced hormone-dependent phosphorylation at S211. This change in GR phosphorylation was associated with its decreased nuclear retention and transcriptional activation. Molecular modeling suggests that GR S211 phosphorylation promotes a conformational change, which exposes a novel surface potentially facilitating cofactor interaction. Indeed, S211 phosphorylation enhances GR interaction with MED14 (vitamin D receptor interacting protein 150). Interestingly, in U2OS cells expressing a nonphosphorylated GR mutant S211A, the expression of IGF-binding protein 1 and interferon regulatory factor 8, both MED14-dependent GR target genes, was reduced relative to cells expressing wild-type receptor across a broad range of hormone concentrations. In contrast, the induction of glucocorticoid-induced leucine zipper, a MED14-independent GR target, was similar in S211A- and wild-type GR-expressing cells at high hormone levels, but was reduced in S211A cells at low hormone concentrations, suggesting a link between GR phosphorylation, MED14 involvement, and receptor occupancy. Phosphorylation also affected the magnitude of repression by GR in a gene-selective manner. Thus, GR phosphorylation at S211 and S226 determines GR transcriptional response by modifying cofactor interaction. Furthermore, the effect of GR S211 phosphorylation is gene specific and, in some cases, dependent upon the amount of activated receptor.

Indexed as

Gene Expression RegulationAmino Acid SequenceAntibodies, Phospho-SpecificCell Line, TumorCurcuminEgtazic AcidHumansKineticsLigandsMediator ComplexModels, BiologicalModels, MolecularMolecular Sequence DataMutationPeptidesPhosphorylation1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl esterAntibodies, Phospho-SpecificCurcuminEgtazic AcidLigandsMED14 protein, humanMediator ComplexPeptidesPhosphoserineReceptors, GlucocorticoidTrans-Activators

Identifiers

PMID18483179
PMCPMC2725771
OpenAlexW1974454557

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.